Final results of a long-term, clinical follow-up in fatty liver patients
- 1 January 2009
- journal article
- research article
- Published by Informa UK Limited in Scandinavian Journal of Gastroenterology
- Vol. 44 (10), 1236-1243
- https://doi.org/10.1080/00365520903171284
Abstract
Objective. There is increasing focus on non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to conduct a long-term clinical follow-up of patients with biopsy-confirmed fatty liver without inflammation or significant fibrosis (pure fatty liver), to analyse for potential risk factors at the time of index liver biopsy important for survival and the development of cirrhosis and to describe the causes of death. Material and methods. Patients were linked through their personal identification number to the Danish National Registry of Patients and the Register of Causes of Death. All admissions, discharge diagnoses and causes of death during follow-up were collected. All surviving patients were invited to a clinical follow-up. Results. The follow-up period was 20.4 and 21.0 years, respectively, for the NAFLD and alcoholic fatty liver disease (AFLD) groups. Two NAFLD patients (1.2%) developed cirrhosis during the follow-up period versus 54 (22%) AFLD patients. Sixty-four percent of 178 surviving patients out of an original cohort of 417 patients attended the clinical follow-up. In NAFLD patients, none of the risk factors studied was significant in relation to the risk of death. Patients with AFLD died primarily from cirrhosis and other alcohol-related disorders, whereas in patients with NAFLD the main causes of death were cardiovascular disease and cancer. Conclusions. For patients with pure non-alcoholic fatty liver, survival was good and independent of the histological, clinical and biochemical characteristics at the time of biopsy; the main causes of death were cardiovascular disease and cancer.Keywords
This publication has 33 references indexed in Scilit:
- Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight lossHepatology, 2004
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology, 2003
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeHepatology, 2002
- Prevalence of the Metabolic Syndrome Among US AdultsJAMA, 2002
- Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely ObeseGastroenterology, 2001
- Association of nonalcoholic fatty liver disease with insulin resistanceAmerican Journal Of Medicine, 1999
- The natural history of nonalcoholic fatty liver: A follow-up studyHepatology, 1995
- The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 yearsHepatology, 1990
- Nonalcoholic steatohepatitis: A study of 49 patientsHuman Pathology, 1989
- Alcohollike liver disease in nonalcoholicsGastroenterology, 1988